Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

CDT | Conduit Pharmaceuticals Inc

Index	-	P/E	218.55	EPS (ttm)	0.02	Insider Own	65.30%	Shs Outstand	13.98M	Perf Week	-26.37%
Market Cap	30.19M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	2.17M	Perf Month	-54.78%
Income	0.55M	PEG	-	EPS next Q	-	Inst Own	25.31%	Short Float / Ratio	0.17% / 0.05	Perf Quarter	-53.82%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	1.29%	Short Interest	0.00M	Perf Half Y	-52.51%
Book/sh	2.73	P/B	1.77	EPS next Y	-	ROA	0.68%	Target Price	-	Perf Year	-
Cash/sh	0.04	P/C	107.81	EPS next 5Y	-	ROE	0.73%	52W Range	5.07 - 25.00	Perf YTD	-52.88%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	3.21%	52W High	-80.68%	Beta	0.35
Dividend %	-	Quick Ratio	0.17	Sales past 5Y	0.00%	Gross Margin	-	52W Low	-4.73%	ATR	2.37
Employees	3	Current Ratio	0.17	Sales Q/Q	-	Oper. Margin	0.00%	RSI (14)	31.50	Volatility	23.64% 22.81%
Optionable	No	Debt/Eq	0.04	EPS Q/Q	-708.82%	Profit Margin	-	Rel Volume	0.27	Prev Close	6.03
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	0.00%	Avg Volume	80.38K	Price	4.83
Recom	-	SMA20	-54.14%	SMA50	-54.64%	SMA200	-53.20%	Volume	21,757	Change	-19.90%

Sep-22-23 09:01AM	Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination (GlobeNewswire)
Sep-20-23 05:40PM	Murphy Canyon Acquisition Corp. Announces Stockholder Approval of the Proposed Combination with Conduit Pharmaceuticals Limited (ACCESSWIRE) -8.94%
Sep-13-23 08:30AM	Presidio Property Trust, Inc. Announces Establishment of a Special Committee of the Board and Exploration of Strategic Alternatives (GlobeNewswire)
Sep-07-23 04:30PM	Murphy Canyon Acquisition Corp. Announces Postponement of Its Special Meeting of Stockholders for Approving Its Initial Business Combination With Conduit (ACCESSWIRE)
Aug-31-23 04:05PM	Murphy Canyon Acquisition Corp. Announces Postponement of its Special Meeting of Stockholders for Approving its Initial Business Combination with Conduit (ACCESSWIRE)
08:30AM	Loading…
Aug-16-23 08:30AM	SEC Declares Form S-4 Registration Statement "Effective" for Proposed Business Combination of Murphy Canyon Acquisition Corp. with Conduit Pharmaceuticals Limited (ACCESSWIRE)

Conduit Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of clinical assets to address the unmet medical needs of patients, through exclusive relationships. Its medical needs in the areas of autoimmune disease and idiopathic male infertility. The company is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Heilbron Jack Kendrick	Former CEO,director&10% owner	Sep 22	Option Exercise	0.00	4,060,250	0	4,060,250	Sep 26 05:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CDT | Conduit Pharmaceuticals Inc

Upgrade your FINVIZ experience